The authors presented a biomimetic nanomedicine by coating cancer cell-mitochondria hybrid membrane on the surface of Gboxin-loaded nanoparticles. An additional design element uses a reactive oxygen species responsive polymer to facilitate at-site Gboxin release.
[Nature Communications]
